Vivani Medical Inc (VANI): Kapitalisasi marang pendapatan

Simbol lan logo merek Vivani (VANI)

The price-to-sales multiple history demonstrates current dynamics, where the value of describes the current level for Vivani Medical, Inc. (VANI). Growth is supported by the creation of sustained-release drug delivery systems that foster strong patient loyalty. The business foundation is the replacement of frequent GLP-1 injections with semi-annual implants for obesity treatment, while the technical base is provided by certified high-precision laboratories with equipment in pristine condition.

VANI Multiplikator P/S Vivani (04.07.2022 - 15.11.2026)

Rincian analitis perusahaan Vivani Medical Inc (VANI)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Analisis umum perusahaan:VANI Vivani Medical, Inc.
Barang utama Vivani Medical

The high volatility of Vivani Medical, Inc. (VANI) is driven by the absence of current cash flows pending the completion of implant clinical trials. The current stage of development leaves the business dependent on regulatory decisions, neutralizing operational resilience. By analyzing the price-to-sales ratio trend, an investor determines the value of a single dollar of sales, assessing market expectations for future growth. Ignoring the historical values of this multiple leads to overpaying for the asset during a correction period.

Pesaing Vivani Medical, Inc.

Kapitalisasi marang pendapatan Boston Scientific Corporation BSX|Multiplikator P/S EW (Edwards Lifesciences)|ResMed Corp (RMD) - Rega marang dodolan|Insulet Corp - Multiplikator P/S|ZBH (zimmerbiomet.com) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (NuVasive) - Multiplikator P/S|TransMedics Corp (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion, Inc. AORT|Multiplikator P/S ENOV (enovis.com)|Multiplikator P/S Integra LifeSciences Corp IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (IRADIMED CORPORATION) - Kapitalisasi marang pendapatan|Embecta Corp. - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Corp) - Multiplikator P/S|Rega marang dodolan AxoGen Inc AXGN|Rasio rega marang pendapatan SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Multiplikator rega marang pendapatan|Multiplikator P/S BVS (bioventus.com)|Multiplikator P/S OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Multiplikator P/S|Koefisien rega marang pendapatan Blade Air Mobility SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Ophthalmic)|Rasio rega marang pendapatan clearpointneuro.com|Kapitalisasi marang pendapatan Stereotaxis, Inc. (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical - Kapitalisasi marang volume dodolan|XTNT (Xtant Medical Holdings) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan NMTC|Rasio rega marang pendapatan Modular Medical Inc|Rega marang dodolan Myomo Inc MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc.)|Rasio rega marang pendapatan VVOS (vivoslife.com)|enVVeno Medical Corp. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan SINT (sintx.com)|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - Multiplikator P/S|Axonics Modulation Technologies (AXNX) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BIOL (Biolase, Inc.)|Dynatronics - Rasio kapitalisasi marang pendapatan|Paragon 28, Inc. - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan INVO Bio (INVO)